Pre-Exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) Prevention | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for Pre-Exposure Prophylaxis (PrEP) for HIV prevention, effective May 15, 2026. Here's what billing teams need to do.

CMS PrEP coverage has been a moving target since the Affordable Care Act preventive services mandate, and this 2026 modification adds another layer your billing team needs to account for before the effective date of May 15, 2026. The policy does not list specific CPT or HCPCS codes in the available data — but PrEP billing touches multiple code families across medication administration, lab work, and preventive office visits. If your practice bills for HIV prevention services, this change deserves your attention now.

Quick-Reference Table

CMS PrEP Coverage Criteria and Medical Necessity Requirements 2026

The CMS PrEP coverage policy sits at the intersection of ACA preventive services law and Medicare billing rules — and that intersection has been legally contested. Here's the background that matters for billing.

The U.S. Preventive Services Task Force (USPSTF) gave PrEP an "A" recommendation in 2019. Under the ACA, that recommendation required most insurers to cover PrEP without cost-sharing. For Medicare, coverage of preventive services is governed separately, and PrEP's pathway into Medicare has followed a different track than commercial insurance.

The 2026 modification reflects CMS's ongoing work to align PrEP coverage with both USPSTF guidance and evolving legal interpretations around mandatory preventive coverage. The real issue here is that the Braidwood v. Becerra litigation challenged the USPSTF mandate — and CMS has had to recalibrate how it frames PrEP coverage as a result. If you're billing for PrEP services across a mixed Medicare/commercial payer mix, your compliance officer needs to be in the loop before May 15, 2026.

For Medicare beneficiaries, PrEP-related medical necessity documentation typically needs to show that a patient is at high risk for HIV acquisition. That means documented risk factors — sexual behavior history, injection drug use, or an HIV-positive partner. Vague documentation doesn't hold up on audit. Your clinical staff need to understand what goes into the note, not just what goes on the claim.

PrEP billing under Medicare involves several distinct service types: the office visit to assess candidacy, the required lab panel before initiation (HIV testing, kidney function, hepatitis B/C, STI screening), follow-up visits every 90 days, and the medication itself. Each of these has its own billing path, and this policy modification may affect how CMS treats each one. Without specific codes listed in the policy data, your team should verify current coding guidance through your Medicare Administrative Contractor (MAC) before the effective date.

Prior authorization is not typically required for PrEP under Medicare Part D for the medication itself, but coverage rules for the associated clinical services — particularly the preventive visit and lab work — depend on how you code and document the encounter. Getting that wrong generates claim denial exposure fast.

CMS PrEP Exclusions and Non-Covered Indications

The available policy data does not list specific exclusions. However, based on CMS's general approach to PrEP coverage, your billing team should know where coverage breaks down.

PrEP is covered as a preventive service — not as treatment. If a patient already has HIV, PrEP is not appropriate and not covered. Billing PrEP-related codes for a patient with a confirmed HIV diagnosis is a documentation and compliance problem, not just a claim denial.

Coverage also depends on which Medicare part applies. Part D covers the medication (tenofovir-based regimens, most commonly). Part B covers the clinical services — the visits and labs. That split creates reimbursement complexity. If your practice dispenses or coordinates medication access, make sure your billing team knows where Part B ends and Part D begins.

Coverage Indications at a Glance

CMS PrEP Billing Guidelines and Action Items 2026

This is where the rubber meets the road. The policy modification is effective May 15, 2026. You have a defined window to get your workflows right.

CPT, HCPCS, and ICD-10 Codes for PrEP Under This CMS Policy

The policy data available for this modification does not list specific CPT, HCPCS, or ICD-10 codes. This is a real gap — and it matters for your billing team.

Do not guess at codes. Do not apply codes from a previous policy version without confirming they're still valid under the 2026 modification.

Here's what you should do instead:

• Check the CMS Medicare Coverage Database directly for associated NCDs or LCDs tied to HIV prevention services.
• Query your MAC for any local coverage determinations related to preventive HIV services, PrEP initiation, and follow-up care.
• Review the USPSTF PrEP recommendation statement for the clinical criteria that typically map to billing documentation requirements.
• If your practice uses a revenue cycle management vendor or billing consultant, send them this policy update and ask them to confirm the correct code set for your payer mix before May 15, 2026.

When code data becomes available through the full policy document at app.payerpolicy.org/p/cms/377-v1, update your charge capture immediately.